NZ303251A - Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy - Google Patents

Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy

Info

Publication number
NZ303251A
NZ303251A NZ303251A NZ30325196A NZ303251A NZ 303251 A NZ303251 A NZ 303251A NZ 303251 A NZ303251 A NZ 303251A NZ 30325196 A NZ30325196 A NZ 30325196A NZ 303251 A NZ303251 A NZ 303251A
Authority
NZ
New Zealand
Prior art keywords
esters
photochemotherapy
aminolevulinic acid
aminolevulinic
photosensitising agents
Prior art date
Application number
NZ303251A
Other languages
English (en)
Inventor
Karl Erik Giercksky
Johan Moan
Qian Peng
Harald Steen
Trond Warloe
Alf Bjorseth
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ303251(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9504948.2A external-priority patent/GB9504948D0/en
Priority claimed from GBGB9525822.4A external-priority patent/GB9525822D0/en
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of NZ303251A publication Critical patent/NZ303251A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ303251A 1995-03-10 1996-03-08 Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy NZ303251A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9504948.2A GB9504948D0 (en) 1995-03-10 1995-03-10 Compounds
GBGB9525822.4A GB9525822D0 (en) 1995-12-18 1995-12-18 Compounds
PCT/GB1996/000553 WO1996028412A1 (en) 1995-03-10 1996-03-08 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy

Publications (1)

Publication Number Publication Date
NZ303251A true NZ303251A (en) 2000-10-27

Family

ID=26306657

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ303251A NZ303251A (en) 1995-03-10 1996-03-08 Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy

Country Status (19)

Country Link
US (1) US6034267A (enExample)
EP (1) EP0820432B1 (enExample)
JP (1) JP3955093B2 (enExample)
KR (1) KR100444007B1 (enExample)
CN (1) CN1137087C (enExample)
AT (1) ATE202076T1 (enExample)
AU (1) AU708076B2 (enExample)
CA (1) CA2215069C (enExample)
CZ (1) CZ291132B6 (enExample)
DE (3) DE122006000051I1 (enExample)
ES (1) ES2157424T3 (enExample)
FR (1) FR05C0042I2 (enExample)
HU (1) HU225148B1 (enExample)
LU (1) LU90956I2 (enExample)
NL (2) NL300176I1 (enExample)
NO (3) NO318379B1 (enExample)
NZ (1) NZ303251A (enExample)
PT (1) PT820432E (enExample)
WO (1) WO1996028412A1 (enExample)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US5895786A (en) 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2777782B1 (fr) * 1998-04-22 2001-05-18 Alexandre Marti Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
US6223071B1 (en) 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
WO2001007159A2 (en) 1999-07-28 2001-02-01 Genset Integration of biochemical protocols in a continuous flow microfluidic device
JP3970492B2 (ja) * 1999-12-14 2007-09-05 コスモ石油株式会社 ピーリング用組成物
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
NO20002428D0 (no) 2000-05-10 2000-05-10 Radiumhospitalets Forskningsst Hudpreparat
US6454790B1 (en) * 2000-07-21 2002-09-24 Ceramoptec Industries, Inc. Treatment for Barrett's syndrome
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
DE50012291D1 (de) * 2000-11-06 2006-04-27 Hofstetter Alfons Tumorzellenidentifizierungsverfahren
EP1346059B1 (en) * 2000-11-29 2012-05-23 PCI Biotech AS Photochemical internalization for delivery of molecules into the cytosol
AU2210402A (en) * 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for virus-mediated molecule delivery into the cyosol
EP1312353A1 (en) * 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
WO2003086460A2 (en) * 2002-04-05 2003-10-23 Candela Corporation High fluence rate activation of photosensitizers for dermatological applications
DE10301917B4 (de) * 2003-01-17 2007-02-01 Gerhard Saalmann Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
DE10312659A1 (de) * 2003-03-21 2004-10-07 Universität Regensburg 5-Aminolävulinsäurederivate und ihre Verwendung
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) * 2004-03-26 2004-04-28 Photocure Asa Compounds
BRPI0418784B1 (pt) 2004-04-28 2014-08-19 Cosmo Oil Co Ltd Composição restauradora de cabelo, e, método não-terapêutico para restaurar cabelo
JP2005350418A (ja) * 2004-06-11 2005-12-22 Shibuya Kogyo Co Ltd 標的細胞の死滅方法と標的細胞を死滅させるための薬剤及び該薬剤の製造装置
JP5034032B2 (ja) 2004-09-29 2012-09-26 Ｓｂｉファーマ株式会社 腫瘍診断剤
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
US20070225518A1 (en) * 2006-03-22 2007-09-27 Zvi Malik 5-Aminolevulinic acid salts and their use
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
JP5098051B2 (ja) 2007-04-05 2012-12-12 Ｓｂｉファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
AU2014200004B2 (en) * 2007-12-12 2016-10-27 Photocure Asa Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
AU2008337067A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
AU2009247547B2 (en) 2008-05-13 2013-10-10 Cosmo Trade & Service Co., Ltd. Agent for improving lawn grass qualities
US8563605B2 (en) 2008-05-14 2013-10-22 Sbi Pharmaceuticals Co., Ltd. Therapeutic agent for male sterility
CA2735426A1 (en) 2008-09-01 2010-03-04 Swedish Pharma Ab New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis
CN101745102B (zh) * 2008-12-16 2013-08-07 上海复旦张江生物医药股份有限公司 5-氨基酮戊酸及其衍生物的组合物及其用途
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
CA2763221C (en) * 2009-05-26 2019-01-08 The General Hospital Corporation Method and apparatus for dermal delivery of a substance
WO2010142457A1 (en) * 2009-06-11 2010-12-16 Photocure Asa Semi-solid compositions and pharmaceutical products
AU2010257752B2 (en) * 2009-06-11 2015-04-09 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
KR101133770B1 (ko) * 2009-10-27 2012-04-09 주식회사 엔씨테크론 메틸 5-아미노레불리네이트 염산염의 제조방법과 이를 이용한 여드름 및 피부 개선을 위한 피부 외용 화장료 조성물 및 이의 제조방법
JP2013521251A (ja) 2010-03-01 2013-06-10 フォトキュア エイエスエイ 美容組成物
EP2394642A1 (en) 2010-06-10 2011-12-14 Universite De Geneve 5-ALA ester formulations and use thereof
US20130211215A1 (en) 2010-06-23 2013-08-15 Photocure Asa Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent
CA2804337A1 (en) 2010-07-09 2012-01-12 Photocure Asa Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
US9012502B2 (en) 2010-09-14 2015-04-21 Sbi Pharmaceuticals Co., Ltd. Cancer heat therapy-enhancing agent
EP2623486B1 (en) * 2010-09-30 2019-11-06 COSMO TRaDE & SERVICE CO., LTD. 5-aminolevulinic acid-containing solid fertilizer and process for producing same
JP6323978B2 (ja) 2010-12-24 2018-05-16 アークレイ株式会社 癌細胞の検出方法
CN102617378B (zh) * 2011-01-26 2016-04-27 上海泺安医药技术有限公司 一种2-(3’-氨基-2’-氧-丙基)丙二酸酯盐及制备
CN102649769B (zh) * 2011-02-25 2015-12-16 上海泺安医药技术有限公司 一种盐酸氨基乙酰丙酸酯的制备工艺
CN102649768B (zh) * 2011-02-25 2016-05-25 上海泺安医药技术有限公司 一种盐酸氨基乙酰丙酸的制备工艺
CN102649767A (zh) * 2011-02-25 2012-08-29 上海泺安医药技术有限公司 一种n-取代氨基乙酰丙酸及其酯制备新工艺
CN102179010B (zh) * 2011-05-27 2013-01-09 吉林大学 脑胶质瘤光动力直接照射治疗装置
EP2727603B1 (en) * 2011-07-01 2023-09-06 SBI Pharmaceuticals Co., Ltd. Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
BR112014014847B1 (pt) 2011-12-19 2022-08-16 Photocure Asa Aparelho de aplicação de luz portátil, autônomo, para tratamento fotodinâmico da vulva, e kit
WO2013092936A2 (en) 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
JP5836402B2 (ja) 2012-01-25 2015-12-24 Ｓｂｉファーマ株式会社 腫瘍診断剤
EP2835094A4 (en) 2012-04-05 2016-03-09 Sbi Pharmaceuticals Co Ltd DEVICE FOR DETERMINING THE METASTASE OF CANCER ON WEEKLY LYMPHOTIC NODES
RU2635563C2 (ru) 2012-08-03 2017-11-14 ФотоКьюэр АСА Соединения
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
CN105899201A (zh) 2013-12-20 2016-08-24 盖尔德马研究及发展公司 光损伤的皮肤的脉冲光动力治疗
EP3095464A1 (en) 2015-05-19 2016-11-23 Universite De Geneve 5-ala derivatives and use thereof
GB201522311D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
EP3389716B1 (en) 2015-12-17 2022-03-23 Photocure ASA Method of photodynamic therapy (pdt) for bladder cancer
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN112010772A (zh) 2016-01-26 2020-12-01 赵鸣 5-氨基酮戊酸及其衍生物的盐化合物和应用
ES2859777T3 (es) 2017-02-06 2021-10-04 3Skin As Composición de filtro solar
EP3636256B1 (en) 2017-05-31 2024-07-03 SBI Pharmaceuticals Co., Ltd. Prophylactic or therapeutic agent for hyperactive bladder
CN107976508A (zh) * 2017-11-27 2018-05-01 上海百灵医药科技有限公司 一种分析盐酸氨酮戊酸含量和纯度的方法
EP3868372A1 (en) 2020-02-19 2021-08-25 JLP Health GmbH A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer
CN113651708A (zh) * 2021-08-17 2021-11-16 湖南复瑞生物医药技术有限责任公司 一种5-氨基酮戊酸酯化物的制备及后处理方法
KR20250154511A (ko) 2023-03-07 2025-10-28 포토큐어 에이에스에이 방광암 치료
WO2026052815A1 (en) 2024-09-05 2026-03-12 Photocure Asa Use of hal in a method for predicting bladder cancer immunotherapy response
WO2026084589A1 (en) 2024-10-14 2026-04-23 Universiteit Van Amsterdam G4-destabiling small molecules for the treatment of x-linked dystonia-parkinsonism.
CN121818922A (zh) * 2026-02-04 2026-04-10 中国医学科学院北京协和医院 一种药物组合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2411382C3 (de) * 1974-03-09 1979-09-06 C.H. Boehringer Sohn, 6507 Ingelheim 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
GB2058077B (en) * 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
JPH0745502B2 (ja) * 1987-11-10 1995-05-17 株式会社トクヤマ 新規化合物及びそれを含む組成物
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JP2767318B2 (ja) * 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
EP0553116A1 (en) * 1990-10-05 1993-08-04 Queen's University At Kingston Porphyrin derivatives
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition

Also Published As

Publication number Publication date
HUP9800460A3 (en) 1998-08-28
ATE202076T1 (de) 2001-06-15
FR05C0042I2 (enExample) 2009-10-30
NO974163L (no) 1997-09-09
WO1996028412A1 (en) 1996-09-19
ES2157424T3 (es) 2001-08-16
CA2215069A1 (en) 1996-09-19
DE69613365T2 (de) 2002-05-02
NL300176I2 (nl) 2005-05-02
EP0820432B1 (en) 2001-06-13
DE122006000051I1 (de) 2007-01-04
US6034267A (en) 2000-03-07
FR05C0042I1 (enExample) 2005-02-12
EP0820432A1 (en) 1998-01-28
LU90956I2 (fr) 2002-11-13
DE69613365D1 (de) 2001-07-19
NL300207I2 (nl) 2005-12-01
NO2005019I1 (no) 2005-09-26
CZ291132B6 (cs) 2002-12-11
NO2005019I2 (no) 2007-04-23
NL300176I1 (nl) 2005-05-02
DE122006000051I2 (de) 2010-07-08
NO974163D0 (no) 1997-09-09
NL300207I1 (nl) 2005-12-01
JPH11501914A (ja) 1999-02-16
PT820432E (pt) 2001-09-28
CZ284897A3 (cs) 1998-03-18
AU4950096A (en) 1996-10-02
AU708076B2 (en) 1999-07-29
NO2005024I2 (no) 2007-04-23
HU225148B1 (en) 2006-07-28
CN1178521A (zh) 1998-04-08
HUP9800460A2 (hu) 1998-07-28
NO318379B1 (no) 2005-03-14
KR100444007B1 (ko) 2004-12-03
JP3955093B2 (ja) 2007-08-08
NO2005024I1 (no) 2005-11-14
CA2215069C (en) 2006-09-12
CN1137087C (zh) 2004-02-04

Similar Documents

Publication Publication Date Title
CA2215069A1 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
TR199801642T2 (xx) Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
AU1400801A (en) Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
KR950005823A (ko) 5-아미노-8-메틸-7-피롤리디닐퀴놀린-3-카르본산유도체
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
EP0518299A3 (en) Phosphonic acid derivatives, production and use thereof
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
AU586477B2 (en) Hexenoic acids
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
ATE66920T1 (de) Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
IL108246A0 (en) Nonatetraenoic acid derivates, their preparation and pharmaceutical compositions containing them
ATE92461T1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired